🇺🇸 FDA
Pipeline program

cognitive-behavioral withdrawal regulation strategies

000522656

Phase 3 other active

Quick answer

cognitive-behavioral withdrawal regulation strategies for Tobacco Dependence is a Phase 3 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tobacco Dependence
Phase
Phase 3
Modality
other
Status
active

Clinical trials